Clinical Trial Update: COMP-4 Supplementation and Brachial Artery FMD [Phase 1, Phase 2]

View source ↗

Summary

The UCLA-sponsored COMP-4 supplementation trial evaluating brachial artery flow-mediated dilation in aging and endothelial dysfunction has completed (Phase 1/2)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction

Drugs mentioned

• COMP-4

Snippet

Sponsor: University of California, Los Angeles | Conditions: Aging, Endothelial Dysfunction | Phase 1, Phase 2 | Status: COMPLETED